DR. REDDY'S LABORATO

500124
End-of-day quote. End-of-day quote  - 06/18
5284.6INR -0.07%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.
Sales per Business
20192020
INR
(in Million)
%INR
(in Million)
%
Global Generics 122,90379.9% 138,12379.1%
Pharmaceutical Services and Active Ingredients 24,14015.7% 25,74714.7%
Proprietary Products 4,7503.1% 7,9494.6%
Others 2,0581.3% 2,7811.6%
Sales per region
20192020
INR
(in Million)
%INR
(in Million)
%
United States 69,29945% 76,02843.5%
Others 40,44926.3% 49,58328.4%
India 28,80418.7% 32,08918.4%
Russia 15,2999.9% 16,9009.7%
Managers
Name Title
Erez Israeli Chief Executive & Operating Officer
Parag Agarwal Chief Financial Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Sandeep Poddar Secretary & Compliance Officer
Kalpana Jaisingh Morparia Independent Non-Executive Director
Bruce Leonard Andrews Carter Independent Non-Executive Director
Sridar Arvamudhan Iyengar Independent Non-Executive Director
Prasad Raghava Menon Lead Independent Director
Leo Puri Independent Director
Shareholders
Name Equities %
Dr. Reddy's Holdings Ltd. 41,325,300 24.9%
First Sentier Investors (Australia) IM Ltd. 5,826,106 3.50%
SBI Funds Management Pvt Ltd. 4,306,394 2.59%
Aditya Birla Sun Life Amc Ltd. (Investment Management) 3,294,086 1.98%
BlackRock Fund Advisors 3,071,172 1.85%
GIC Pte Ltd. (Investment Management) 2,773,174 1.67%
Life Insurance Corp of India 2,650,211 1.59%
The Vanguard Group, Inc. 2,477,291 1.49%
Mirae Asset Global Investments (India) Pvt Ltd. 2,458,614 1.48%
ICICI Prudential Life Insurance Co. Ltd. (Invt Port) 2,218,921 1.33%
Company contact information
Banjara Hills 3 8-2-337 Road
IN-500 016 Hyderabad, Andhra Pradesh


Phone : +91 40 4900 2900
Fax : +91 40 4900 2999
web site : https://www.drreddys.com/
Markets and indexes
-
- Main Market
- S&P BSE SENSEX / CNX Nifty
Stock Exchange Codes
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
DR. REDDY'S LABORATORIES LIMITED0.29%11 813
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668
MERCK & CO., INC.-6.34%193 981
NOVO NORDISK A/S20.59%188 360
ASTRAZENECA PLC14.47%151 865
BRISTOL-MYERS SQUIBB COMPANY7.16%148 417
AMGEN INC.3.81%137 135
SANOFI11.79%130 457
GLAXOSMITHKLINE PLC6.07%98 277
JIANGSU HENGRUI MEDICINE CO., LTD.-23.09%70 523
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-22.77%63 368
BAYER AG9.54%61 438
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.85%52 846
DAIICHI SANKYO COMPANY, LIMITED-28.98%43 629
ASTELLAS PHARMA INC.21.89%32 733